Genfit.fr

Categories: New newsletter subcribe

130Newsletters

0Subscriptions

Click here to subscribe to Genfit.fr

Newsletters

GENFIT: Announces Results from Interim An alysis of RESOLVE-IT Phase 3 Trial of Elafibranor in Adults with NASH and Fib rosis Genfit.fr
5 years ago
GENFIT: Annual Shareholders Meeting of Ju ne 11, 2020 – Availability of P reparatory Documents Genfit.fr
5 years ago
GENFIT: Updates to 2020 Financial Cale ndar Genfit.fr
5 years ago
GENFIT Reports Full-Year 2019 Financial R esults and Corporate Update Genfit.fr
5 years ago
GENFIT: Update on Regulatory and Clinical Activities Amid the COVID-19 Pandemic Genfit.fr
5 years ago
Correction - GENFIT: Unblinding of Phase 3 RESOLVE-IT Data Deferred Genfit.fr
5 years ago
GENFIT: Unblinding of Phase 3 RESOLVE-IT Data Deferred Genfit.fr
5 years ago
GENFIT: 2020 Financial Calendar Genfit.fr
5 years ago
Season's Greetings from GENFIT!⛄ Genfit.fr
5 years ago
GENFIT : Résultats de l’Assemb lée Générale Ordinaire et Ex traordinaire du 27 novembre 2019 Genfit.fr
5 years ago
GENFIT: Outcome of the Ordinary and Ext raordinary Shareholders’ Meeting of November 27, 2019 Genfit.fr
5 years ago
GENFIT: Positive 42-month DSMB Recommendati on for Continuation of Phase 3 RESOLVE- IT Study of Elafibranor in NASH Genfit.fr
5 years ago
GENFIT Announces Results of NIS4, an In vestigational Non-Invasive NASH Diagnostic, at AASLD 2019 Genfit.fr
5 years ago
GENFIT : Nouvelles données présen tées au Liver Meeting 2019 de l’ AASLD Genfit.fr
5 years ago
GENFIT Announces New Data to be Present ed at AASLD Liver Meeting 2019 Genfit.fr
5 years ago
GENFIT: Reports Third Quarter 2019 Financ ial Information Genfit.fr
5 years ago
Letter to shareholders - October 2019 Genfit.fr
5 years ago
GENFIT : Prochains rendez-vous investisseur s Genfit.fr
5 years ago
GENFIT: Upcoming Investor Events Genfit.fr
5 years ago
Genfit: H1 2019 Results and R&D Pipe line Progression Genfit.fr
5 years ago

© 2025